Abola, P. and Jabishvili, G. 2025. Incidence of adverse and safety events in individuals with Parkinson’s disease treated with catechol-o-methyltransferase inhibitor opicapone as an add-on to levodopa treatment: a systematic review and meta-analysis. Prospects in Pharmaceutical Sciences. 23, 4 (Aug. 2025), 175–185. DOI:https://doi.org/10.56782/pps.563.